Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-19-041351
Filing Date
2019-11-07
Accepted
2019-11-07 07:01:36
Documents
68
Period of Report
2019-11-07

Document Format Files

Seq Description Document Type Size
1 6-K ortx-6k_20191107.htm 6-K 2070725
  Complete submission text file 0001564590-19-041351.txt   7345180

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT ortx-20191107.xml EX-101.INS 1443098
3 XBRL TAXONOMY EXTENSION SCHEMA ortx-20191107.xsd EX-101.SCH 63399
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ortx-20191107_cal.xml EX-101.CAL 52747
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ortx-20191107_def.xml EX-101.DEF 195250
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE ortx-20191107_lab.xml EX-101.LAB 485155
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ortx-20191107_pre.xml EX-101.PRE 359944
Mailing Address 108 CANNON STREET LONDON X0 EC4N 6EU
Business Address 108 CANNON STREET LONDON X0 EC4N 6EU 011-44-0-203-3846700
Orchard Therapeutics plc (Filer) CIK: 0001748907 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38722 | Film No.: 191198079
SIC: 2836 Biological Products, (No Diagnostic Substances)